ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
5 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
same1
|
43 |
16K |
6 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
43
|
16K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
same1
|
43 |
16K |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
43
|
16K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
same1
|
43 |
16K |
12 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
43
|
16K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Appendix 4C - Quarterly
|
|
same1
|
43 |
16K |
11 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
43
|
16K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
same1
|
13K |
4.8M |
2 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
13K
|
4.8M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
same1
|
13K |
4.8M |
12 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
13K
|
4.8M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
same1
|
291 |
126K |
9 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
291
|
126K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
same1
|
291 |
126K |
1 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
291
|
126K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
same1
|
291 |
126K |
4 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
291
|
126K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
same1
|
291 |
126K |
7 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
291
|
126K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1801 Phase 2a Antimicrobial Study Underway
|
|
same1
|
291 |
126K |
6 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
291
|
126K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
same1
|
233 |
84K |
4 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
233
|
84K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
same1
|
233 |
84K |
3 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
233
|
84K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
same1
|
233 |
84K |
2 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
233
|
84K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Antimicrobial Data Published in Peer-Reviewed Journal
|
|
same1
|
233 |
84K |
0 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
233
|
84K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
1 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
3 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
0 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
same1
|
8.9K |
3.3M |
0 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Update on BTX 1801 Phase 2a Clinical Study
|
|
same1
|
115 |
52K |
1 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
115
|
52K
|
1
|
|
ASX - By Stock
|
LYC |
lyc mid day rally
|
|
same1
|
2 |
446 |
3 |
23/09/10 |
23/09/10 |
ASX - By Stock
|
2
|
446
|
3
|
|